Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation

AIMS/HYPOTHESIS: Approximately 50% of organ donors develop hyperglycaemia in intensive care, which is managed with insulin therapy. We aimed to determine the relationships between donor insulin use (DIU) and graft failure in pancreas transplantation. METHODS: UK Transplant Registry organ donor data...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapey, Iestyn M., Summers, Angela, Khambalia, Hussein, Yiannoullou, Petros, Fullwood, Catherine, Hanley, Neil A., Augustine, Titus, Rutter, Martin K., van Dellen, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099796/
https://www.ncbi.nlm.nih.gov/pubmed/33665687
http://dx.doi.org/10.1007/s00125-021-05411-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099796/
https://www.ncbi.nlm.nih.gov/pubmed/33665687
http://dx.doi.org/10.1007/s00125-021-05411-9

Ejemplares similares